Kezar Life Sciences (NASDAQ:KZR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Kezar Life Sciences (KZR) operate in?

Kezar Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kezar Life Sciences Stock (NASDAQ: KZR) stock price, news, charts, stock research, profile.

Open	$6.40
Close	-
Volume / Avg.	1.26K / 44.27K
Day Range	$6.40 - $6.40
52 Wk Range	5.20 - 11.35
Market Cap	$42.83M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	1.09%
Days to Cover	2.76

Recent News

Penny Stock Kezar Life Sciences Rejects Acquisition Deal From Concentra Biosciences At $1.10/Share, Shelves Mid-Stage Lupus Nephritis Study

Kezar Life Sciences halted its PALIZADE Phase 2b lupus nephritis trial due to fatal adverse events. Meanwhile, its PORTOLA Phase 2a autoimmune hepatitis trial progresses, with topline data expected in 2025. Kezar also rejected a buyout proposal from Concentra Biosciences.

Vandana Singh

Why Saratoga Investment Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

FDA Put Brakes On Penny Stock Kezar Life Sciences' Mid-Stage Study For Lead Development Candidate After Patient Deaths

Kezar Life Sciences' zetomipzomib drug for lupus nephritis has been placed on clinical hold by the FDA following serious safety concerns. The company continues its autoimmune hepatitis trials while reallocating resources from other programs.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Open	$6.40
Close	-
Volume / Avg.	1.26K / 44.27K
Day Range	$6.40 - $6.40
52 Wk Range	5.20 - 11.35
Market Cap	$42.83M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	1.09%
Days to Cover	2.76

About Kezar Life Sciences Inc

Sector

Health Care

Industry

Biotechnology

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Kezar Life Sciences (KZR) stock?

You can purchase shares of Kezar Life Sciences (NASDAQ:KZR) through any online brokerage.

View our list of the best stock brokerages

Who are Kezar Life Sciences (KZR) competitors?

Other companies in Kezar Life Sciences’s space includes: Serina Therapeutics (AMEX:SER), Outlook Therapeutics (NASDAQ:OTLK), Fortress Biotech (NASDAQ:FBIO), Connect Biopharma Hldgs (NASDAQ:CNTB) and Immuneering (NASDAQ:IMRX).

What is the forecast, or price target, for Kezar Life Sciences (KZR) stock?

Kezar Life Sciences has a consensus price target of $9.00.

What is the current price for Kezar Life Sciences (KZR)?

The stock price for Kezar Life Sciences (NASDAQ: KZR) is $5.87 last updated February 13, 2025 at 4:04 PM EST.

Does Kezar Life Sciences (KZR) pay a dividend?

There are no upcoming dividends for Kezar Life Sciences.

When is Kezar Life Sciences (NASDAQ:KZR) reporting earnings?

Kezar Life Sciences’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Kezar Life Sciences (KZR) going to split?

There is no upcoming split for Kezar Life Sciences.

What sector and industry does Kezar Life Sciences (KZR) operate in?

Kezar Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Kezar Life Sciences

Kezar Life Sciences (KZR) Forecast